Appointments

866.320.4573

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Franck Rahaghi, MD

877.463.2010

Franck Rahaghi, MD

Appointed: 2003

Franck Rahaghi, MD
Department: Pulmonary Disease Florida
Location: Florida, Weston
Mail Code WESTON
2950 Cleveland Clinic Boulevard
Weston, FL 33331
WorkAppointment:877.463.2010
DeskDesk:954.659.5450
WorkFax:954.659.5451
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Franck Rahaghi, MD, MH, FCCP, is Chair of Quality at Cleveland Clinic Florida Hospital and Clinic. He has also been Medical Director of the Respiratory Care Department since 2003.

In 2003, Dr. Rahaghi became Staff Attending in Pulmonary Critical Care as well as Director of the Pulmonary Hypertension Clinic, Cleveland Clinic Florida. In 2005, he became Head of the Pulmonary Education and Rehabilitation Department as well as a member of the Internal Review Board, responsible for correct conduct of research and clinical trials at Cleveland Clinic Florida. In the following year, he was named Director of Quality and Outcomes Development in the Division of Medicine.

Formerly, Dr. Rahaghi was a Fellow in Medicine/Pulmonary/Critical Care at New York Presbyterian-Weill Cornell Medical Center in New York City (1999-2003). He was also an Instructor in genetic medicine at the Cornell University Weill School of Medicine (2001-2003) and assisted in the design and implementation of clinical trials at Cornell (Activated Protein C and  IFN gamma-1b) (2000-2003).

In 1999, he was a Visiting Associate Physician at Rockefeller University Hospital, New York, N.Y. He participated in the Categorical Internal Medicine Program at the University of Illinois at Chicago from 1997-1999. From 1996-1997, he participated in the Categorical Internal Medicine Program.at the University of Minnesota, Minn. In 2000, he became a Hospitalist at Sharp Memorial Hospital, San Diego. The following year, he was a Visitor at the University of California-San Diego Interventional Pulmonology Department/Pulmonary Hypertension.

Professional Highlights

  • Expert in pulmonary hypertension, serving South Florida (Broward and Palm Beaches)
  • Head of the first comprehensive Pulmonary Education Department
  • Chair of Quality in Cleveland Clinic Florida, advancing outcome-based improvements in quality

Education & Fellowships

Fellowship - New York Presbyterian Hospital - Columbia Univ. & Weill Cornell Medical Center
Pulmonary&Critical Care
New York, NY
2003
Residency - University of Illinois at Chicago Medical Center
Internal Medicine
Chicago, IL USA
1999
Internship - University of Minnesota Hospital and Clinic
Internal Medicine
Minneapolis, MN USA
1997
Medical School - University of California-San Francisco School of Medicine
San Francisco, CA USA
1996
Graduate - University of California-Berkeley
Berkeley, CA USA
1994
Undergraduate - University of California-San Diego
La Jolla, CA USA
1991

Certifications

  • Internal Medicine- Pulmonary Disease
  • Internal Medicine- Critical Care Medicine

Specialty Interests

pulmonary hypertension, Alpha-1 anti-trypsin deficiency/COPD, interstitial lung diseases, including: collagen vascular diseases (Scleroderma) and pulmonary fibrosis, critical care

Awards & Honors

  • Innovator Award, Cleveland Clinic, for innovation in medical technology, 2005-2007
  • Leadership Certificate, Cleveland Clinic (promising future leaders at Cleveland Clinic), 2006
  • Fellow, American College of Chest Physicians, 2005
  • Cornell Award for Best Fellow Research, 2004 

Additional Training

  • Enhancing Team Effectiveness, professional development program for health professions faculty, jointly sponsored by the Association of American Medical Colleges and Harvard Medical School
  • Cleveland Clinic Leadership Course, Cleveland Clinic, 2006  
  • Advanced Training in Quality, American College of Executive Physicians

Innovations & Patents

Convertible dual-lumen endotracheal tube: U.S. Patent Pending, 2005

Memberships

  • College of Chest Physicians
  • Society of Critical Care Medicine
  • Pulmonary Hypertension Association/Research
  • American Medical Association
  • American Society of Executive Physicians,Vanguard Member

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 1/21/2014, Dr. Rahaghi has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Rahaghi receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Actelion Pharmaceuticals, Ltd.
  • Baxter Healthcare Corporation
  • Bayer Healthcare Pharmaceuticals, Inc.
  • CSL Behring
  • Forest Pharmaceuticals
  • Gilead Sciences, Inc.
  • Grifols, S.A.
  • United Therapeutics Corporation

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
  • French
  • Persian
  • Farsi